anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The present invention relates to a kind of emulsion of sterilizing, and it is made by the method for following high-temperature sterilization：A. the emulsion is gradually preheated into (120) until preheating temperature T1, the temperature are in the stability limit of the emulsion；B. ultra-high temperature sterilization (130) is carried out by irrigating the emulsion so preheated, it includes, i. (131) are heated by the way that the emulsion of preheating is infused under desired temperature T2, in the sterilizing chamber filled with vapor until sterilising temp T2, ii. stable (132) in the sterilising temp, iii. cools down (133) under temperature T3 after sterilizing in a vacuum；C. lower gradually cool down (150) of stirring are to storage temperature T4.The emulsion of the sterilizing is free of preservative.
PURPOSE:To obtain the powder consisting of a globular silicone resin having specific particle diameter and excellent in UV rays-screening property and smoothness by subjecting the surface of the powder to coating treatment with titanium oxide ultrafine particles previously coated with alumina or its hydrate. CONSTITUTION:The surface of ultrafine particles of titanium oxide is previously subjected to coating treatment with alumina or its hydrate to afford titanium oxide fine particles having 0.001-0.1mum average particle diameter. The surface of a globular silicone resin is subjected to coating with these ultrafine particles to provide the objective complex globular powder consisting of a globular silicone resin having 1-30mum average particle diameter. A polyorganosiloxane coating film is preferably formed on the further outer layer of ultrafine particles of titanium oxide. This complex globular powder body is excellent in UV rays- screening property and smoothness and does not exhibit light-activating action. This complex globular powder is a hydrophilic powder free from deterioration of an organic base even in a state irradiated with light when blended with a cosmetic. A cosmetic free from discolor, occurrence of odor, irritation to skin is obtained.
Oral Alprazolam treatment 0.5 mg daily combined with oral GABA treatment 600 mg daily for 3 months. Alprazolam treatment thereafter ended, and study subjects will continue with oral GABA treatment 600 mg daily only for another 3 months.
The patients in the intervention group scheduled for angiography were administered the Beck Anxiety Scale, and then they underwent conscious, deep breathing exercises along with synchronized breathing training. The face-to-face teaching and application of the breathing exercises took an average of 15-20 minutes.
The invention discloses a medicine composition. The medicine composition is composed of a component 1 of a gastric acid secretion inhibitor, a component 2 of macrolide antibiotic, a component 3 of beta-lactam antibiotic, and a component 4 of a gastro spasm inhibitor. Due to the synergistic effect of the gastro spasm inhibitor and the other medicines, the time of exerting efficacy actions in the stomach, of medicines is prolonged, and gastric acid and gastric pain are rapidly eased. The union for peptic ulcers and the eradication for helicobacter pylori of the medicine composition are superior to the union and the eradication of the existing medicine composition without the gastro spasm inhibitor, and side effects can be reduced. The components in the medicine composition may perform chemical reactions with each other, so that a part of the components need to be prepared into dry particles or enteric pellets at first. The medicine composition can be used for manufacturing medicines for treating peptic ulcers and helicobacter pylori infection.
Background: Higher obesity prevalence and poorer diet quality disproportionately impacting groups based on income and race/ethnicity may be partially attributed to the home food environment. This study examined home- and individual-level diet quality with weight status among racially/ethnically diverse households. Methods: This cross-sectional study included African American (AA) and Hispanic/Latinx (H/L) households with preschool-age children (n = 97). Home-level diet quality was based on comprehensive home food inventories and individual-level diet quality was based on 24-hour dietary recalls; scores were estimated with the Healthy Eating Index. Child and adult appropriate weight categories based on BMI were estimated with measured heights and weights. Multiple linear regression models (independent variable: weight status, outcome: diet quality scores) with an interaction term for weight status and race/ethnicity and adjusting for potential confounding factors were used to estimate adjusted mean diet quality scores. Postestimation pairwise comparisons of these scores were used to look for within and between group differences by weight status and race/ethnicity. Results: Home-level diet quality scores were significantly higher among H/L households compared to AA counterparts regardless of weight status. AA parents with BMI <30 and AA children with BMI <85th percentile had poorer individual-level diet quality scores compared to AA parents and children of lower weight status and all H/L parents and children. Conclusions: These findings offer evidence that race/ethnicity modifies the relationship between diet quality and weight among AA and H/L households. Future research needs to examine the distinctive ways race/ethnicity shapes the relationship between weight and diet quality in these households.
PURPOSE: Foot tuberculosis is a rare form of osteoarticular tuberculosis, accounting for less than 1% of cases. It presents unique diagnostic challenges due to its nonspecific clinical features and overlapping symptoms with other conditions. This study aimed to investigate the clinical presentation, radiographic findings, and prognosis of foot tuberculosis, with the goal of improving early recognition and appropriate intervention.
METHODS: A prospective study was conducted between November 2016 and July 2021, involving 39 patients diagnosed with foot tuberculosis. Clinical examinations, laboratory tests, X-rays, and MRI evaluations were performed to aid in the diagnosis. Biopsy was conducted on patients with radiological lesions. Patients were treated with an 18-month course of antitubercular therapy (ATT). Foot Function Index (FFI) scores were recorded before and after treatment. Statistical analysis was conducted to assess factors impacting prognosis.
RESULTS: Unilateral foot involvement was observed in all patients, with a male predominance (61.5%) and a mean age of 31.3 years. The most common symptoms were pain and edema, with sinus tracts present in 17.9% of patients. Radiographic findings showed cystic and sclerotic lesions, with the "spina ventosa" appearance primarily affecting the metatarsal bones. MRI played a valuable role in early detection. Histopathological examination confirmed tuberculosis in all cases, and acid-fast bacilli were found in 23% of patients. Most patients (79.4%) responded well to ATT without requiring surgery. Factors such as high initial ESR, delayed ATT initiation, multiple lesions, and tarsal involvement were associated with unfavourable outcomes.
CONCLUSION: Foot tuberculosis presents with nonspecific symptoms, leading to misdiagnosis and delays in appropriate treatment. Clinical examination, radiographic evaluation, and biopsy are essential for accurate diagnosis. Early initiation of ATT is crucial for favourable outcomes. Factors such as high initial ESR, delayed treatment initiation, multiple lesions, and tarsal involvement negatively impact prognosis. This study highlights the importance of recognizing foot tuberculosis and provides insights into its clinical presentation, radiographic features, and treatment outcomes, facilitating timely intervention and improved patient management.
Patients will receive standard care from their oncologist. An assessment of health related quality of life will be conducted at regular oncology clinic visits at baseline and 3,6,9,and 12 months.
PURPOSE:To develop the titled material having no toxicity and superior in discoloration resistance, hardness variation characteristic with the lapse of time, by using a Ga alloy having a specified compsn. as liquid metal, and Pd, Zn, In, Pt, Ag, Cu and Au as metal powder. CONSTITUTION:The alloy composed of 1-45% In, 1-30% Sn. 0.01-5% Ge, and the balance Ga is used as liquid metal of substitute for Hg in conventional Hg amalgam as the titled material. The metal powder milled finely by atomizing method and having a compsn. composed of 0-20% Pd, 0-5% Zn, 0-10% In, 0-10% Pt, 0-40% Ag, 0-30% Cu and the balance Au is used as metal powder to be used together with said liquid metal. The titled material having no amalgam toxicity due to non-use of Hg and superior in discoloration resistance and hardness variation characteristic with the lapse of time is obtd.
TENORMIN is excreted by the kidneys; consequently dosage should be adjusted in cases of severe impairment of renal function. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function. Atenolol excretion would be expected to decrease with advancing age.

No significant accumulation of TENORMIN occurs until creatinine clearance falls below 35 mL/min/1.73m2. Accumulation of atenolol and prolongation of its half-life were studied in subjects with creatinine clearance between 5 mL/min and 105 mL/min. Peak plasma levels were significantly increased in subjects with creatinine clearances below 30 mL/min.

The following maximum oral dosages are recommended for elderly, renally-impaired patients and for patients with renal impairment due to other causes:

Some renally-impaired or elderly patients being treated for hypertension may require a lower starting dose of TENORMIN: 25 mg given as one tablet a day. If this 25 mg dose is used, assessment of efficacy must be made carefully. This should include measurement of blood pressure just prior to the next dose ("trough" blood pressure) to ensure that the treatment effect is present for a full 24 hours.

Although a similar dosage reduction may be considered for elderly and/or renally-impaired patients being treated for indications other than hypertension, data are not available for these patient populations.

Patients on hemodialysis should be given 25 mg or 50 mg after each dialysis; this should be done under hospital supervision as marked falls in blood pressure can occur.
Disclosed is a method for the comprehensive analysis of nucleic acid samples and a detector composition for use in the method. The method involves amplifying nucleic acid fragments of interest using a primer that can form a hairpin structure; sequence-based coupling of the amplified fragments to detector probes; and detection of the coupled fragments. The amplified fragments are coupled by hybridization and coupling, preferably by ligation, to detector probes. A hairpin structure formed at the end of the amplified fragments facilitates coupling of the fragments to the probes. The method allows detection of the fragments where detection provides some sequence information for the fragments. The method allows a complex sample of nucleic acid to be quickly and easily cataloged in a reproducible and sequence-specific manner. The method can also be used to detect amplified fragments having a known sequence.
PURPOSE:To exactly decide the virus infection of Pogostemon patchouly by using the antiviral serum obtd. by using the virus PaMMV which indicates a gentle mosaic-like disease symptom on the leaves of the Pogostemon patchouly when said virus infects the Pogostemon patchouly. CONSTITUTION:The infected leave juice of the Pogostemon patchouly infected with the PaMMV is inoculated to the vegetable of Chenopodiaceae and the juice obtd. from the inoculated leaves infected therewith is centrifugally separated. The supernatant thereof is then taken. A nonionic surfactant is added to the supernatant which is then repeatedly subjected to the centrifugal sepn. on a cane sugar cushion to purify the PaMMV. The purified PaMMV is infected to a mammal to immunize the mammal, from which the antiviral serum is obtd. The virus disease of the Pogostemon patchouly is diagnosed by an agar gel diffusion method, latex agglutination reaction method, fluorescent antibody method, enzyme antibody method or immune electron microscopy, etc., using the said antiviral serum.
PCT No. PCT/AU90/00556 Sec. 371 Date Aug. 12, 1991 Sec. 102(e) Date Aug. 12, 1991 PCT Filed Nov. 20, 1990 PCT Pub. No. WO91/07992 PCT Pub. Date Jun. 13, 1991.The present invention relates to the use of leukaemia inhibitory factor (LIF), alone or in combination with other cytokines such as interleukin-6 (IL-6) and/or transforming growth factor  alpha (TGF alpha ) and/or fibroblast growth factor (FGF), to stimulate the proliferation and/or differentiation of mammalian satellite cells. The present invention also contemplates a method comprising myoblast transfer therapy whereby LIF, alone or in combination with other cytokines, is/are employed to proliferate and/or differentiate mammalian satellite cells into myoblasts. The present invention is also directed to a cell activating composition and a pharmaceutical composition comprising LIF alone or in combination with other cytokines to promote proliferation and/or differentiation of mammalian satellite cells in vitro and in vivo, respectively.
PROBLEM TO BE SOLVED: To obtain a cellulose deriv. which neither decomposes in vivo nor causes diarrhea due to adsorbing protein and has high adsorbing capacity of uremia matter, and its usage. SOLUTION: This cellulose deriv. has more than one formylalkyl groups or formylbenzyl groups as substituents on its side chain. This compd. is manufactured by O-alkylation or O-benzylation of hydroxide group, which has been formed by hydrolyzing an acetyl group of cellulose acetate, by a haloalkyl or a halobenzyl both having an acetal group, then, an aldehyde group is formed on its side chain by hydrolyzing the acetal group by acid. A medicinal composition (adsorbent of uremia matter, medicine for nephritis and renal failure), food, and food additives contg. the cellulose deriv. as their effective component are prepared. The medicinal composition has high adsorbing characteristics to uremia matter such as urea and shows no protein adsorption which is considered as the cause of diarrhea.
Phosphatidylcholine (PC) is a form of choline, a nutrient that is sometimes referred to as Vitamin B4 or Vitamin J. Choline is for normal growth everywhere in the body, including in the brain. PC is a naturally occurring substance and can be found in many different kinds of food including milk, liver, and eggs so most people get enough choline. However, when a woman is pregnant and her baby is growing many new cells, more PC may be needed. Research has suggested that the presence of adequate amounts of choline during pregnancy and breastfeeding can help ensure healthy fetal brain development and may have long-lasting positive effects on cognitive function. Problems in behavioral and cognitive development into childhood have been reported in children of mothers who used cannabis during gestation. Alternatively, two studies of maternal choline levels during pregnancy have reported beneficial effects of higher levels on childhood behavioral and cognitive development. This study assesses whether a higher dose of choline taken during pregnancy will have positive results on offspring development.

Participants in this double-blind study will be randomly assigned to receive either placebo or 1028 mg of choline daily throughout pregnancy, until delivery. Vital signs will be taken, potential side effects will be assessed, and study medication will be given at each visit. Blood samples will be taken at enrollment, and approximately at weeks 16, 22, 28, 34. Children will be followed and assessed until 3 months of age.
Medulloblastoma is the most common pediatric brain cancer, with about five cases per million in the pediatric population. Current treatment strategies have a 5-year survival rate of 70% or more but frequently lead to long-term neurocognitive defects, and recurrence is relatively high. Genomic sequencing of medulloblastoma patients has shown that DDX3X, which encodes an RNA helicase involved in the process of translation initiation, is among the most commonly mutated genes in medulloblastoma. The identified mutations are 42 single-point amino acid substitutions and are mostly not complete loss-of-function mutations. The pathological mechanism of DDX3X mutations in the causation of medulloblastoma is poorly understood, but several studies have examined their role in promoting cancer progression. This review first discusses the known roles of DDX3X and its yeast ortholog Ded1 in translation initiation, cellular stress responses, viral replication, innate immunity, inflammatory programmed cell death, Wnt signaling, and brain development. It then examines our current understanding of the oncogenic mechanism of the DDX3X mutations in medulloblastoma, including the effect of these DDX3X mutations on growth, biochemical functions, translation, and stress responses. Further research on DDX3X's mechanism and targets is required to therapeutically target DDX3X and/or its downstream effects in medulloblastoma progression.
Participants will first receive an inhaled long-acting muscarinic antagonist (LAMA) once daily for 4 weeks. After a 2 week washout period, they will then receive the fixed-dose combination product \[LAMA plus long-acting beta2-agonist (LABA)\] once daily for 4 weeks.
Achieving rapid clotting and clot stability are important unmet goals of clinical management of noncompressible hemorrhage. This study reports the development of a spatiotemporally controlled release system of an antihemorrhagic drug, etamsylate, in the management of internal hemorrhage. Gly-Arg-Gly-Asp-Ser (GRGDS) peptide-functionalized chitosan nanoparticles, with high affinity to bind with the GPIIa/IIIb receptor of activated platelets, were loaded with the drug etamsylate (etamsylate-loaded GRGDS peptide-functionalized chitosan nanoparticles; EGCSNP). Peptide conjugation was confirmed by LCMS, and the delivery system was characterized by DLS, SEM, XRD, and FTIR. In vitro study exhibited 90% drug release till 48 h fitting into the Weibull model. Plasma recalcification time and prothrombin time tests of GRGDS-functionalized nanoparticles proved that clot formation was 1.5 times faster than nonfunctionalized chitosan nanoparticles. The whole blood clotting time was increased by 2.5 times over clot formed under nonfunctionalized chitosan nanoparticles. Furthermore, the application of rheometric analysis revealed a 1.2 times stiffer clot over chitosan nanoparticles. In an in vivo liver laceration rabbit model, EGCSNP spatially localized at the internal injury site within 5 min of intravenous administration, and no rebleeding was recorded up to 3 h. The animals survived for 3 weeks after the injury, indicating the strong potential of the system for the management of noncompressible hemorrhage.
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules produced in cellular damage or stress, and they can activate the innate immune system. DAMPs contain multiple types of molecules, including nucleic acids, proteins, ions, glycans, and metabolites. Although these endogenous molecules do not trigger immune response under steady-state condition, they may undergo changes in distribution, physical or chemical property, or concentration upon cellular damage or stress, and then they become DAMPs that can be sensed by innate immune receptors to induce inflammatory response. Thus, DAMPs play an important role in inflammation and inflammatory diseases. In this review, we summarize the conversion of homeostatic molecules into DAMPs; the diverse nature and classification, cellular origin, and sensing of DAMPs; and their role in inflammation and related diseases. Furthermore, we discuss the clinical strategies to treat DAMP-associated diseases via targeting DAMP-sensing receptors.
The invention discloses a lignan triglucoside compound and a preparation method and application thereof. The molecular formula of the lignan triglucoside compound is C38H54O21. The preparation method for the lignan triglucoside compound comprises the following steps of: extracting crushed Castanea henryi (Skan) Rehd. et Wils shells in an organic solvent, separating to obtain leaching liquor, extracting the leaching liquor, and concentrating the extracted liquor to obtain an extract; and performing chromatographic separation and purification on the extract, and thus obtaining the lignan triglucoside compound, wherein the organic solvent is one or more of methanol, ethanol, n-butanol and acetone. The lignan triglucoside compound with a novel structure is extracted and separated from the Castanea henryi (Skan) Rehd. et Wils shells; and the compound has good tyrosinase inhibiting activity, can be used for preparing tyrosinase inhibiting medicaments, whitening cosmetics or whitening health-care food, and has a good development prospect.
UNLABELLED: Hospitals are subject to strict microbial control. Stringent cleaning and confinement measures in hospitals lead to a decrease in microbial diversity, but an increase in resistance genes. Given the rise of antimicrobial resistances and healthcare-associated infections, understanding the hospital microbiome and its resistome is crucial. This study compared the microbiome and resistome at different levels of confinement (CL) within a single hospital. Using amplicon sequencing, shotgun metagenomics, and genome/plasmid reconstruction, we demonstrate that microbial composition differs in a stable way between the CLs and that the most restrictive confinement level CL1 had the lowest microbial but the highest functional diversity. This CL also exhibited a greater abundance of functions related to virulence, disease, defense, and stress response. Comparison of antibiotic resistance also showed differences among CLs in terms of the selection process and specific mechanisms for antimicrobial/antibiotic resistance. The resistances found in the samples of CL1 were mostly mediated via antibiotic efflux pumps and were mainly located on chromosomes, whereas in the other, less restrictive CL antibiotic resistances were more present on plasmids. This could be of particular importance for patient-related areas (CL2), as the potential spread of antibiotic resistances could be a major concern in this area. Our results show that there are differences in the microbiome and resistome even within a single hospital, reflecting room utilization and confinement. Since restrictive confinement selects for resistant microorganisms, strategies are required to deepen our understanding of dynamic processes of microbiome and resistome within hospital environments.
IMPORTANCE: Effective measures to combat antibiotic resistances and healthcare-associated infections are urgently needed, including optimization of microbial control. However, previous studies have indicated that stringent control can lead to an increase in the resistance capacities of microbiomes on surfaces. This study adds to previous knowledge by focusing on the conditions in a single hospital, resolving the microbiomes and their resistomes in three different confinement levels (CL): operating room, patient-related areas, and non-patient-related areas. We were able to identify stable key taxa; profiled the capacities of taxa, functions, and antimicrobial resistances (AMR); and reconstruct genomes and plasmids in each CL. Our results show that the most restrictive CL indeed had the highest functional diversity, but that resistances were mostly encoded on chromosomes, indicating a lower possibility of resistance spread. However, clever strategies are still required to strike a balance between microbial control and selective pressures in environments where patients need protection.